Sartorius Aktiengesellschaft (SRT) - Cash Flow Conversion Efficiency

Latest as of June 2025: 0.040x

Based on the latest financial reports, Sartorius Aktiengesellschaft (SRT) has a cash flow conversion efficiency ratio of 0.040x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€150.20 Million ≈ $175.60 Million USD) by net assets (€3.79 Billion ≈ $4.44 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Sartorius Aktiengesellschaft - Cash Flow Conversion Efficiency Trend (2013–2024)

This chart illustrates how Sartorius Aktiengesellschaft's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Sartorius Aktiengesellschaft debt and liabilities for a breakdown of total debt and financial obligations.

Sartorius Aktiengesellschaft Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Sartorius Aktiengesellschaft ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Northam Platinum Holdings Ltd
JSE:NPH
0.152x
Sailun Jinyu Group Co Ltd
SHG:601058
0.071x
Geovis Technology Co Ltd
SHG:688568
0.019x
KINGFISHER ADR/2 LS-1571
F:KFI2
N/A
Yunnan Lincang Xinyuan Germanium Industrial Co Ltd
SHE:002428
-0.027x
Shenghe Resources Holding Co Ltd
SHG:600392
0.023x
Nuvalent Inc
NASDAQ:NUVL
-0.083x
Noble Corporation plc
NYSE:NE
0.061x

Annual Cash Flow Conversion Efficiency for Sartorius Aktiengesellschaft (2013–2024)

The table below shows the annual cash flow conversion efficiency of Sartorius Aktiengesellschaft from 2013 to 2024. For the full company profile with market capitalisation and key ratios, see market value of Sartorius Aktiengesellschaft.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 €3.90 Billion
≈ $4.56 Billion
€976.20 Million
≈ $1.14 Billion
0.250x -15.90%
2023-12-31 €2.76 Billion
≈ $3.22 Billion
€821.30 Million
≈ $960.19 Million
0.298x +7.84%
2022-12-31 €2.66 Billion
≈ $3.11 Billion
€734.20 Million
≈ $858.36 Million
0.276x -45.60%
2021-12-31 €1.72 Billion
≈ $2.01 Billion
€873.20 Million
≈ $1.02 Billion
0.508x +39.15%
2020-12-31 €1.40 Billion
≈ $1.64 Billion
€511.52 Million
≈ $598.03 Million
0.365x +4.57%
2019-12-31 €1.08 Billion
≈ $1.26 Billion
€377.19 Million
≈ $440.97 Million
0.349x +38.87%
2018-12-31 €973.39 Million
≈ $1.14 Billion
€244.52 Million
≈ $285.87 Million
0.251x -1.89%
2017-12-31 €806.56 Million
≈ $942.95 Million
€206.51 Million
≈ $241.43 Million
0.256x +10.70%
2016-12-31 €736.80 Million
≈ $861.40 Million
€170.42 Million
≈ $199.24 Million
0.231x +18.96%
2015-12-31 €644.75 Million
≈ $753.78 Million
€125.36 Million
≈ $146.56 Million
0.194x -25.39%
2014-12-31 €497.66 Million
≈ $581.82 Million
€129.69 Million
≈ $151.62 Million
0.261x +13.63%
2013-12-31 €450.25 Million
≈ $526.39 Million
€103.26 Million
≈ $120.72 Million
0.229x --

About Sartorius Aktiengesellschaft

F:SRT Germany Medical Instruments & Supplies
Market Cap
$6.69 Billion
€5.72 Billion EUR
Market Cap Rank
#2966 Global
#584 in Germany
Share Price
€167.20
Change (1 day)
-0.48%
52-Week Range
€146.60 - €205.00
All Time High
€829.87
About

Sartorius Aktiengesellschaft provides bioprocess solutions, and lab products and services worldwide. The company offers multi-parallel, benchtop, single-use, stainless steel, cell culture, rocking motion, and microbial bioreactors; software apps for bioreactors and cell culture shake flasks; fermenters; cell culture media, biolayer interferometry, microbiological testing, and fluid management pro… Read more